Olympus reports FY results
- BySeeking Alpha-
Olympus (OCPNF): FY Profit of¥12.92B.Revenue of¥730.54B (-3.3% Y/Y)Press Release
Olympus (OCPNF): FY Profit of¥12.92B.Revenue of¥730.54B (-3.3% Y/Y)Press Release
Los Angeles, USA, April 22, 2021 (GLOBE NEWSWIRE) -- Benign Prostatic Hyperplasia Devices Market Expected to Rise by a CAGR of 25.41% by 2026 | DelveInsightThe Benign Prostatic...
Medi-Tate, which develops minimally-invasive treatments for the lower urinary tract, will become the Japanese medical device company's Israel R&D center.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Buy | Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Neutral | Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Neutral | Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 45.31 | 45.48 | 44.56 | +0.87 | +1.96% | 1.68M | Toronto | |||
| 27.89 | 27.92 | 27.72 | +0.17 | +0.61% | 1.22M | Toronto | |||
| 8.36 | 8.37 | 8.34 | +0.02 | +0.24% | 243.75K | Toronto | |||
| 0.02 | 0.00 | 0.00 | 0.000 | 0.00% | 155.80K | CSE | |||
| 3.10 | 3.19 | 3.05 | -0.11 | -3.43% | 814.83K | Toronto | |||
| 38.65 | 39.32 | 38.03 | -0.57 | -1.45% | 406.67K | Toronto | |||
| 87.56 | 88.56 | 87.17 | -0.28 | -0.32% | 6.40M | Toronto | |||
| 4.06 | 4.28 | 4.06 | -0.31 | -7.09% | 1.16M | Toronto | |||
| 67.80 | 68.61 | 67.72 | -0.41 | -0.60% | 233.31K | Toronto | |||
| 0.53 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 39.40 | 39.75 | 39.29 | -0.05 | -0.13% | 56.97K | Toronto | |||
| 26.00 | 26.75 | 25.85 | -0.47 | -1.78% | 149.91K | Toronto | |||
| 0.66 | 0.00 | 0.00 | -0.0300 | -4.35% | 653.89K | TSXV | |||
| 61.21 | 61.36 | 60.93 | +0.05 | +0.08% | 3.89M | Toronto | |||
| 116.69 | 117.87 | 115.41 | -1.03 | -0.87% | 119.92K | Toronto |
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.